Therapy using stem cells for the treatment of chronic kidney failure
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/43729 |
Resumo: | This study aimed to describe an alternative therapy for patients with Chronic kidney disease (CKD) using stem cells (ST). To carry out this integrative literature review, articles were surveyed in the following databases: PubMed, Scientific Electronic Library Online (Scielo), Coordination for the Improvement of Higher Education Personnel (CIHEP), Virtual Health Library (VHL). The survey took place between the months of February and September 2023. Chronic kidney disease is the result of progressive and irreversible damage to the nephrons and complications, individuals affected by CKD require adaptation in their lifestyle habits, such as following a restrictive diet, continuous use of medications and are dependent on equipment. Renal Replacement Therapies (RRT) are the treatments commonly used for CKD, namely hemolysis or peritoneal dialysis, another way of RRT currently is kidney transplantation. Despite being very effective, these treatments interfere with the quality of life and physical and mental well-being of patients. The effectiveness of treatment for CKD using CT has the great potential to repair kidney injuries, reducing the development and progression of the disease, acting to improve kidney functions. We conclude that stem cells have great potential as therapeutic agents for people with CKD, in animal and pre-clinical studies, however, given this, there is a need for more studies in humans, to prove the viability, safety and efficacy of CT. |
id |
UNIFEI_6ff6318d7b2964bf40d0dd0a9597eeb7 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/43729 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Therapy using stem cells for the treatment of chronic kidney failureTerapia con células madre para el tratamiento de la insuficiencia renal crónica Terapia com uso de células tronco para tratamento de insuficiência renal crônica Insuficiencia renal crónicaTerapia de reemplazo renalCélulas madre mesenquimatosas.Renal insufficiency chronicRenal replacement therapyMesenchymal stem cells.Insuficiência renal crônicaTerapia de substituição renalCélulas-tronco mesenquimais.This study aimed to describe an alternative therapy for patients with Chronic kidney disease (CKD) using stem cells (ST). To carry out this integrative literature review, articles were surveyed in the following databases: PubMed, Scientific Electronic Library Online (Scielo), Coordination for the Improvement of Higher Education Personnel (CIHEP), Virtual Health Library (VHL). The survey took place between the months of February and September 2023. Chronic kidney disease is the result of progressive and irreversible damage to the nephrons and complications, individuals affected by CKD require adaptation in their lifestyle habits, such as following a restrictive diet, continuous use of medications and are dependent on equipment. Renal Replacement Therapies (RRT) are the treatments commonly used for CKD, namely hemolysis or peritoneal dialysis, another way of RRT currently is kidney transplantation. Despite being very effective, these treatments interfere with the quality of life and physical and mental well-being of patients. The effectiveness of treatment for CKD using CT has the great potential to repair kidney injuries, reducing the development and progression of the disease, acting to improve kidney functions. We conclude that stem cells have great potential as therapeutic agents for people with CKD, in animal and pre-clinical studies, however, given this, there is a need for more studies in humans, to prove the viability, safety and efficacy of CT.Este estudio tuvo como objetivo describir una terapia alternativa para pacientes con Insuficiencia Renal Crónica (IRC) utilizando células madre (CM). Para realizar esta revisión integradora de la literatura, se relevaron artículos en las siguientes bases de datos: PubMed, Biblioteca Científica Electrónica en Línea (Scielo), Coordinación para el Perfeccionamiento del Personal de la Educación Superior (CPPES), Biblioteca Virtual en Salud (BVS). La encuesta se realizó entre los meses de febrero y septiembre de 2023. La insuficiencia renal crónica es el resultado de un daño progresivo e irreversible a las nefronas y pueden ocurrir complicaciones los individuos afectados por IRC requieren adaptación en sus hábitos de vida, como seguir una dieta restrictiva, el uso continuo de medicamentos y dependen del equipamiento. Las terapias de reemplazo renal (TRR) son los tratamientos comúnmente utilizados para la IRC, es decir, hemólisis o diálisis peritoneal, otra forma de TRR actualmente es el trasplante de riñón. A pesar de ser muy eficaces, estos tratamientos interfieren en la calidad de vida y el bienestar físico y mental de los pacientes. La eficacia del tratamiento de la ERC mediante TC tiene el gran potencial de reparar lesiones renales, reduciendo el desarrollo y progresión de la enfermedad, actuando para mejorar las funciones renales. Concluimos que las células madre tienen un gran potencial como agentes terapéuticos para personas con ERC, en estudios animales y preclínicos, sin embargo, ante esto, se necesitan más estudios en humanos, para comprobar la viabilidad, seguridad y eficacia de la TC.Este estudo objetivou descrever a eficácia de uma terapia alternativa para pacientes portadores de Insuficiência Renal Crônica (IRC) com o uso de células tronco (CT). Para a realização dessa revisão de literatura do tipo integrativa, foi realizado o levantamento dos artigos nas bases de dados: PubMed, Scientific Electronic Library Online (Scielo), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Biblioteca Virtual em Saúde (BVS). O levantamento ocorreu entre os meses de Fevereiro e Setembro de 2023. A insuficiência renal crônica é o resultado de uma lesão progressiva e irreversível dos néfrons, indivíduos acometidos por IRC necessitam de adaptação em seus hábitos de vida, como seguir uma dieta restritiva, fazer uso contínuo de medicamentos e são dependentes de equipamentos. As Terapias Renais Substitutivas (TRS) são os tratamentos comumente usados para IRC, sendo elas, hemólise ou diálise peritoneal. Outra maneira de TRS atualmente é o transplante de rins, apesar de muito eficaz, estes tratamentos interferem na qualidade de vida, do bem estar físico e mental dos pacientes. A eficácia do tratamento para IRC utilizando as CT, tem o grande potencial de reparações nas lesões dos rins, reduzindo o desenvolvimento e a progressão da doença, atuando na melhoria das funções renais. Concluímos que as células tronco são grandes potenciais como agentes terapêuticos para os portadores de IRC, em estudos com animais e pré-clínicos, porém diante disso, é visto a necessidade de mais estudos em humanos, para provar a viabilidade, segurança e eficácia das CT.Research, Society and Development2023-10-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4372910.33448/rsd-v12i11.43729Research, Society and Development; Vol. 12 No. 11; e91121143729Research, Society and Development; Vol. 12 Núm. 11; e91121143729Research, Society and Development; v. 12 n. 11; e911211437292525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/43729/35162Copyright (c) 2023 Bruna Gomes Pereira; Thais Aiko Waragaya ; Gabriel Lopes Pinto; Mariana Araújo Muscalu; Giovanna Santos da Silva; Ana Luiza Santos Maldonadohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPereira, Bruna Gomes Waragaya , Thais Aiko Pinto, Gabriel Lopes Muscalu, Mariana Araújo Silva, Giovanna Santos da Maldonado, Ana Luiza Santos 2023-11-08T11:58:58Zoai:ojs.pkp.sfu.ca:article/43729Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-11-08T11:58:58Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Therapy using stem cells for the treatment of chronic kidney failure Terapia con células madre para el tratamiento de la insuficiencia renal crónica Terapia com uso de células tronco para tratamento de insuficiência renal crônica |
title |
Therapy using stem cells for the treatment of chronic kidney failure |
spellingShingle |
Therapy using stem cells for the treatment of chronic kidney failure Pereira, Bruna Gomes Insuficiencia renal crónica Terapia de reemplazo renal Células madre mesenquimatosas. Renal insufficiency chronic Renal replacement therapy Mesenchymal stem cells. Insuficiência renal crônica Terapia de substituição renal Células-tronco mesenquimais. |
title_short |
Therapy using stem cells for the treatment of chronic kidney failure |
title_full |
Therapy using stem cells for the treatment of chronic kidney failure |
title_fullStr |
Therapy using stem cells for the treatment of chronic kidney failure |
title_full_unstemmed |
Therapy using stem cells for the treatment of chronic kidney failure |
title_sort |
Therapy using stem cells for the treatment of chronic kidney failure |
author |
Pereira, Bruna Gomes |
author_facet |
Pereira, Bruna Gomes Waragaya , Thais Aiko Pinto, Gabriel Lopes Muscalu, Mariana Araújo Silva, Giovanna Santos da Maldonado, Ana Luiza Santos |
author_role |
author |
author2 |
Waragaya , Thais Aiko Pinto, Gabriel Lopes Muscalu, Mariana Araújo Silva, Giovanna Santos da Maldonado, Ana Luiza Santos |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Pereira, Bruna Gomes Waragaya , Thais Aiko Pinto, Gabriel Lopes Muscalu, Mariana Araújo Silva, Giovanna Santos da Maldonado, Ana Luiza Santos |
dc.subject.por.fl_str_mv |
Insuficiencia renal crónica Terapia de reemplazo renal Células madre mesenquimatosas. Renal insufficiency chronic Renal replacement therapy Mesenchymal stem cells. Insuficiência renal crônica Terapia de substituição renal Células-tronco mesenquimais. |
topic |
Insuficiencia renal crónica Terapia de reemplazo renal Células madre mesenquimatosas. Renal insufficiency chronic Renal replacement therapy Mesenchymal stem cells. Insuficiência renal crônica Terapia de substituição renal Células-tronco mesenquimais. |
description |
This study aimed to describe an alternative therapy for patients with Chronic kidney disease (CKD) using stem cells (ST). To carry out this integrative literature review, articles were surveyed in the following databases: PubMed, Scientific Electronic Library Online (Scielo), Coordination for the Improvement of Higher Education Personnel (CIHEP), Virtual Health Library (VHL). The survey took place between the months of February and September 2023. Chronic kidney disease is the result of progressive and irreversible damage to the nephrons and complications, individuals affected by CKD require adaptation in their lifestyle habits, such as following a restrictive diet, continuous use of medications and are dependent on equipment. Renal Replacement Therapies (RRT) are the treatments commonly used for CKD, namely hemolysis or peritoneal dialysis, another way of RRT currently is kidney transplantation. Despite being very effective, these treatments interfere with the quality of life and physical and mental well-being of patients. The effectiveness of treatment for CKD using CT has the great potential to repair kidney injuries, reducing the development and progression of the disease, acting to improve kidney functions. We conclude that stem cells have great potential as therapeutic agents for people with CKD, in animal and pre-clinical studies, however, given this, there is a need for more studies in humans, to prove the viability, safety and efficacy of CT. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-10-31 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/43729 10.33448/rsd-v12i11.43729 |
url |
https://rsdjournal.org/index.php/rsd/article/view/43729 |
identifier_str_mv |
10.33448/rsd-v12i11.43729 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/43729/35162 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 12 No. 11; e91121143729 Research, Society and Development; Vol. 12 Núm. 11; e91121143729 Research, Society and Development; v. 12 n. 11; e91121143729 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052632928354304 |